Oak Ridge Investments’s Sarepta Therapeutics SRPT Stock Holding History

Oak Ridge Investments’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-26,483	Closed	-$4.25M	–	187
2020 Q2	$4.25M	Sell	26,483 -2,597	-9%	-$353K	0.36%	95
2020 Q1	$2.85M	Sell	29,080 -3,775	-11%	-$432K	0.29%	99
2019 Q4	$4.24M	Sell	32,855 -3,027	-8%	-$306K	0.31%	102
2019 Q3	$2.7M	Sell	35,882 -3,786	-10%	-$447K	0.2%	106
2019 Q2	$6.03M	Sell	39,668 -1,981	-5%	-$241K	0.42%	93
2019 Q1	$4.96M	Sell	41,649 -4,203	-9%	-$540K	0.32%	101
2018 Q4	$5M	Sell	45,852 -2,597	-5%	-$325K	0.36%	98
2018 Q3	$7.83M	Sell	48,449 -77,258	-61%	-$10.6M	0.43%	87
2018 Q2	$16.6M	Sell	125,707 -5,627	-4%	-$531K	0.94%	36
2018 Q1	$9.73M	Sell	131,334 -51,757	-28%	-$3.45M	0.54%	76
2017 Q4	$10.2M	Sell	183,091 -73,879	-29%	-$3.91M	0.49%	78
2017 Q3	$11.7M	Buy	+256,970	New	+$10.3M	0.47%	79

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Oak Ridge Investments's SRPT Position: Q3 2020 in Review

Oak Ridge Investments sold out of Sarepta Therapeutics (SRPT) in Q3 2020, closing a stake of 26,483 shares — an estimated $4.25M sold.

Oak Ridge Investments first reported a position in SRPT in Q3 2017 and held it in 12 quarters. The position peaked at $16.6M in Q2 2018. 403 funds tracked by Wall St. Rank hold SRPT as of Q3 2020.

Oak Ridge Investments reported no remaining Sarepta Therapeutics position as of Q3 2020 after selling out during the quarter.
Oak Ridge Investments sold 26,483 Sarepta Therapeutics shares in Q3 2020, an estimated $4.25M.
Oak Ridge Investments first reported a position in Sarepta Therapeutics in Q3 2017 and held it in 12 quarters.
Oak Ridge Investments's Sarepta Therapeutics position peaked at $16.6M in Q2 2018.
403 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2020.

Based on Oak Ridge Investments's 13F filing for Q3 2020, filed 12 Nov 2020.